This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

R. Owen Carter, PhD; K. D. McMurrain, Jr., MD
Procter & Gamble Co. Cincinnati

JAMA. 1970;211(12):2017.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Confused and incomplete reports in the lay press have stemmed from recent publications regarding the occurrence of irritant dermatitis and allergic respiratory symptoms among workers involved in the manufacture of enzyme-containing detergents—symptoms attributal to enzyme dust encountered in the factory environment.^1-4 Indications are that this problem is purely industrial and that it is controllable in the factory by improved hygiene and dust-control measures. This letter presents a summary of our data showing that the factory problem in no way extends to the consumer areas as has been implied in some press reports. A substantial body of laboratory and clinical evidence and market experience demonstrates that no problem with the finished enzyme product exists in consumer use.

It is natural for physicians to ask if what has happened in the factory is to be expected among those who use enzyme-containing products in the home. The question of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?